Skip to Content
You are currently on the new version of our website. Access the old version .
GenesGenes
  • Review
  • Open Access

7 November 2019

20 Pages

Gut Microbiota Influences Experimental Outcomes in Mouse Models of Colorectal Cancer

and
Cancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
*
Author to whom correspondence should be addressed.
This article belongs to the Special Issue Animal Modeling in Cancer

Abstract

Colorectal cancer (CRC) is a leading cause of cancer-related deaths worldwide. Mouse models are a valuable resource for use throughout the development and testing of new therapeutic strategies for CRC. Tumorigenesis and response to therapy in humans and mouse models alike are influenced by the microbial communities that colonize the gut. Differences in the composition of the gut microbiota can confound experimental findings and reduce the replicability and translatability of the resulting data. Despite this, the contribution of resident microbiota to preclinical tumor models is often underappreciated. This review does the following: (1) summarizes evidence that the gut microbiota influence CRC disease phenotypes; (2) outlines factors that can influence the composition of the gut microbiota; and (3) provides strategies that can be incorporated into the experimental design, to account for the influence of the microbiota on intestinal phenotypes in mouse models of CRC. Through careful experimental design and documentation, mouse models can continue to rapidly advance efforts to prevent and treat colon cancer.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.